The total B-cell (MHCII+, CD19+) levels were not altered in the NSC243928 treated tumor isografts from the E0771 model and were not detected in the NSC243928 treated tumor isografts from the 4T1 model (Figure S1B). Here, CD19 is linked to neoplasm.